Literature DB >> 19194756

Neurogenic tumors of the pelvis: clinicopathologic features and surgical outcomes using a multidisciplinary team.

Eric J Dozois1, Jarrod C H Wall, Robert J Spinner, David J Jacofsky, Michael J Yaszemski, Franklin H Sim, Steven L Moran, Robert R Cima, Dirk R Larson, Michael G Haddock, Scott H Okuno, David W Larson.   

Abstract

BACKGROUND: Few data exist regarding the outcomes in patients undergoing surgery for pelvic tumors of neurogenic origin. Our aim was to characterize the clinical and pathologic features of pelvic neurogenic tumors and assess surgical outcomes.
METHODS: All patients who underwent operations for pelvic neurogenic tumors at our institution between 1956 and 2004 were identified. Data analyzed included demographics, clinical features, histopathology, local recurrence, and survival.
RESULTS: Eighty-nine patients were identified, of whom 44 were male. Median age was 38 years. The most common presenting symptom was low back or pelvic pain (56%). Malignant lesions were found in 43 patients (48%). Schwannomas were the most common benign tumor (61%) and malignant peripheral nerve sheath tumors the most common malignant lesion (81%). Median tumor size was 9.5 cm (range 0.8-32 cm). Malignant tumors had histopathologic evidence of infiltration of surrounding structures in 49% of cases. Intralesional resection was the most common surgical technique for both benign and malignant tumors. Thirty-day mortality was nil; major morbidity was seen in 13%. Adjuvant therapy was given to 91% of the patients with malignant disease. Five-year local recurrence rates for benign and malignant lesions were 35.9% and 35.0%, respectively. Distant recurrence for malignant lesions was 65.1% at 5 years. Five-year disease-free survival for malignant tumors was 25.9%.
CONCLUSION: Pelvic neurogenic tumors occurring in young patients may be large when detected and present with nonspecific symptoms. Benign and malignant tumors had a high local recurrence rate and survival for malignant tumors was poor. Early detection and aggressive surgical intervention should improve outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19194756     DOI: 10.1245/s10434-009-0344-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  7 in total

1.  Lesions Originating within the Retrorectal Space.

Authors:  A Merchea; E J Dozois
Journal:  J Gastrointest Surg       Date:  2014-05-17       Impact factor: 3.452

2.  Morbidity and functional status of patients with pelvic neurogenic tumors after wide excision.

Authors:  Joseph Alderete; Eduardo N Novais; Eric J Dozois; Peter S Rose; Franklin F Sim
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Surgical Management of Symptomatic Lumbar, Sacral, and Lumbosacral Plexus Tumors: a Peripheral Nerve Unit Experience.

Authors:  Fernando Guedes; Gabriel Elias Sanches; Rosana Siqueira Brown; Rodrigo Salvador Vivas Cardoso; Ana Caroline Siquara-de-Sousa; Agostinho Ascenção; Antônio Carlos Iglesias
Journal:  Acta Neurochir (Wien)       Date:  2021-03-10       Impact factor: 2.216

4.  Lesions originating within the retrorectal space: a diverse group requiring individualized evaluation and surgery.

Authors:  Craig A Messick; Tracy Hull; George Rosselli; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2013-10-22       Impact factor: 3.452

5.  A black esophagus as a result of treatment of inferior vena cava occlusion by a massive pelvic schwannoma.

Authors:  Yazan N AlJamal; Jacob J Billings; Eric J Dozios
Journal:  J Surg Case Rep       Date:  2019-08-14

6.  Pre-operative embolization facilitating a posterior approach for the surgical resection of giant sacral neurogenic tumors.

Authors:  Kangwu Chen; Ming Zhou; Huilin Yang; Zhonglai Qian; Genlin Wang; Guizhong Wu; Xiaoyu Zhu; Zhiyong Sun
Journal:  Oncol Lett       Date:  2013-05-08       Impact factor: 2.967

7.  "We talk it over"--mixed-method study of interdisciplinary collaborations in private practice among urologists and oncologists in Germany.

Authors:  Sandra Beermann; Denny Chakkalakal; Rebecca Muckelbauer; Lothar Weißbach; Christine Holmberg
Journal:  BMC Cancer       Date:  2014-10-04       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.